April 10, 2012
2 min read
Save

DES May Be Preferable to BMS in Oldest Patients

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Among patients aged at least 85 years who underwent PCI, use of drug-eluting stents produced better outcomes compared with bare-metal stents, including lower rates of mortality, despite an overall decline of DES use in that age group.

Perspective from Aravinda Nanjudappa, MD

The study included 471,006 patients from the CathPCI Registry of the National Cardiovascular Data Registry who were at least 65 years of age and underwent PCI between 2004 and 2008. These patients were matched to Medicare fee-for-service data.

From 2005 to 2008, the population of patients at least 85 years of age increased in both elective PCI (7% to 9%) and acute PCI (10% to 13%; P<.001 for both) groups; however, researchers also reported that DES use decreased with age.

Overall, use of DES was associated with lower rates of mortality in those at least 85 years of age (adjusted HR=0.80; 95% CI, 0.77-0.83); age 75 to 84 years (adjusted HR=0.77; 95% CI, 0.75-0.79); and age 65 to 74 years (adjusted HR= 0.73; 95% CI, 0.71-0.75). Risk of rehospitalization for MI was also significantly lower among DES vs. BMS patients, with the greater risk reported with increasing age (P<.001).

For More Information:

  • Wang TY. J Am Coll Cardiol. 2012;59:105-112.